Skip to main content

October 2014

 

 

academics

 

Clinical research courses

Ph.D Admission Notification (Session Spring 2015) at BIT, Mesra

BIT, Mesra is a "Deemed University" under Sec. 3 of the U.G.C. Act 1956. The Board of Governors is responsible for the main functions and overall supervision of activities.

A BRIEF REVIEW ON SUSTAINED RELEASE MATRIX TABLETS OF BACLOFEN

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Singh Surya Pratap*, Soni Shankar Lal, Khinchi Mahaveer Prasad, Gulia Ritu, Namdev Abhisek
Department of pharmaceutics, Kota College of  Pharmacy,
Ranpur, Kota, Rajasthan, India
sp.kota91@gmail.com

ABSTRACT
The objective of the present study was to focus on sustained release matrix tablets of baclofen, for treatment of spastically resulting from multiple sclerosis, flexor spasm and muscular rigidity. Designing effective therapies for Spinal cord injury (SCI) has been a challenging problem because spinal cord injuries are heterogeneous in causality, severity and location of injury.
Effective drug therapy for Spinal cord injury (SCI) first became a reality in 1990 with the finding that the steroid drug methylprednisolone(MP) can significantly improve recovery. Significant advances in recent year, including an effective drug therapy for acute SCI, have improve recovery. In spinal cord injury, pain persist for longer period i.e., several months, hence the long-term treatment is necessary for maintaining the drug concentration in the therapeutic range.
Hence, there is a need of sustained release dosage form. Baclofen,4-amino-3-(4-chlorophenyl)-butyric acid is another structural analog of GABA, which is widely used now a days in the treatment of multiple sclerosis, flexor spasms, muscular rigidity. spinal cord injuries and other spinal cord diseases.

Opening for M.Pharm as Senior Research Associate - Biologics in Hospira

Hospira is the world's leading provider of injectable drugs and infusion technologies. Through our broad, integrated portfolio, we are uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs.
Through our offering of high-quality, lower-cost generic medications, we continue to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system.

Post: Senior Research Associate - Biologics

MACS- Agharkar Research Institute requires positions of JRF in the Botany group of plant sciences devision

Agharkar Research Institute (ARI) is an autonomous, grant-in-aid research institute of the Department of Science and Technology (DST), Goverment of India. It was established in 1946 by the Maharashtra Association for the Cultivation of Science as MACS Research Institute and renamed as ARI in 1992 in honour and memory of its founder Director, late Professor S.P. Agharkar.

Require Pharma Scientist in Dow

Dow (NYSE: DOW) combines the power of science and technology to passionately innovate what is essential to human progress. The Company is driving innovations that extract value from the intersection of chemical, physical and biological sciences to help address many of the world's most challenging problems such as the need for clean water, clean energy generation and conservation, and increasing agricultural productivity.

Applications are invited for the position JRF in GSBTM sponsored project at Indian Institute of Advanced Research

Applications are invited for the position JRF in GSBTM sponsored project in Cell Biology

Interested candidate can appear for interview on 8th Oct 2014 at 11.00 AM for the position of Junior Research Fellow (JRF) in GSBTM sponsored project entitled “Study the role of cFLIP in apoptosis and autophagic signaling by NF-kB pathway in cancer” under the supervision of Dr. Chandramani Pathak, Principal Investigator, Department of Cell Biology, Indian Institute of Advanced Research, Koba Institutional Area, Koba, Gandhinagar-382 007.

Post: Junior Research Fellow

Walk in interview for Senior Research Fellow in Banaras Hindu University

Banaras Hindu University ranks among the first few in the country in the field of academic and research output.

Application are invited for Project Fellow in Osmania University

Osmania University established in 1918, is the seventh oldest in the Country, third oldest in South India and the First in the princely state of Hyderabad. The establishment of Osmania University symbolizes a renaissance in the Indian Educational System and has shown a remarkable resilience throughout its existence. The university is instrumental in propagation of Higher Education to cater the needs of community in the region over nine decades and has grown into one of the major Universities of India.

EFFECT OF MAGNETIC FIELD ON CANCER CELLS

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Rajesh Tiwari1*, Roshan kumar2
1Chemistry Department, Dr. Ghanshyam Singh Post Graduate College, Varanasi
2SBCBE VIT University, Vellore
*Rajesh.tiwari851@gmail.com

ABSTRACT
In 16th century physician were of the opinion that magnet can be used for the treatment or eliminate the diseases from the body. Here the reports about the chemical synthesis, protection, functionalization and application of magnetic nanoparticles of nano structured system. Research of magnetic nanoparticles for targeted drug delivery system and function of magnetic nanoparticles on particular area are reviewed. Use of magnetic nanoparticles for cancer diagnosis has been advancing day by day. This review is related to the multifunctional use of magnetic nanoparticles probes and their use in bio imaging and nano medicine.

Career opportunity for Assistant/Officer-Clinical Research (3 Posts) in Sun Pharma | B.Pharm/M.Pharm

Sun Pharma ranks amongst India's largest pharma companies We’ve built a reputation for speciality therapy leadership and faster- than-industry growth over the last 30 years. From a modest beginning with five people, our team today exceeds 13,000 and growing, put manufacturing base now spans 25 sites across the world. With a market cap of over $ 16 billion, we’re also India’s most valued pharma brand. To keep pace with our growth plans, we require for our Formulation manufacturing plant at Halol (Near Baroda):